Gufic Biosciences Limited (BOM:509079)
India · Delayed Price · Currency is INR 370.05
+9.85 (2.73%)
At close: Jun 16, 2026
Gufic Biosciences Market Cap
Gufic Biosciences has a market cap or net worth of 37.11 billion as of June 16, 2026. Its market cap has decreased by -3.44% in one year.
Market Cap
37.11B
Enterprise Value
40.40B
Revenue
9.44B
Ranking
n/a
PE Ratio
57.82
Stock Price
370.05
Market Cap Chart
Since March 5, 2001, Gufic Biosciences's market cap has increased from 357.14M to 37.11B, an increase of 10,290.88%. That is a compound annual growth rate of 20.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 37.11B | 9.89% |
| Dec 31, 2025 | 33.77B | -26.14% |
| Dec 31, 2024 | 45.72B | 44.52% |
| Dec 29, 2023 | 31.64B | 43.80% |
| Dec 30, 2022 | 22.00B | -4.54% |
| Dec 31, 2021 | 23.05B | 153.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sanofi India | 71.85B |
| FDC Limited | 63.15B |
| Bliss GVS Pharma | 46.35B |
| Novartis India | 32.19B |
| Unichem Laboratories | 31.41B |
| Morepen Laboratories | 27.49B |
| Kwality Pharmaceuticals | 25.91B |
| Venus Remedies | 24.08B |